OTCMKTS:SGIOY Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) Stock Price, News & Analysis $9.14 0.00 (0.00%) As of 09/11/2026 03:57 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsInsider TradesNews and TrendsSEC FilingsShort Interest About Shionogi & Co., Ltd. Unsponsored ADR Stock (OTCMKTS:SGIOY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get SGIOY alerts:Sign Up Key Stats Today's Range$8.81▼$9.4550-Day Range$8.61▼$9.5652-Week Range$7.65▼$12.00Volume114,012 shsAverage Volume89,421 shsMarket Capitalization$15.56 billionP/E Ratio9.14Dividend Yield1.53%Price TargetN/AConsensus RatingBuy Company Overview Shionogi & Co., Ltd. is a Japan-based pharmaceutical company that researches, develops, manufactures and markets prescription medicines. Founded in Osaka in 1878, the company has built its business around drug discovery and has a particular focus on infectious diseases, including antiviral and antibacterial treatments. Shionogi’s products include Xofluza (baloxavir marboxil), an oral treatment for influenza, and Fetcroja (cefiderocol), an antibiotic used for certain difficult-to-treat bacterial infections. The company has also contributed compounds to HIV therapies, including dolutegravir, through its collaboration with ViiV Healthcare. Its research activities have also included central nervous system and pain-related medicines. Headquartered in Osaka, Shionogi serves patients and healthcare providers in Japan and international markets through its own operations, subsidiaries and commercial partnerships. The company is led by President and Chief Executive Officer Isao Teshirogi. Shionogi & Co., Ltd. Unsponsored ADRs trade in the United States under the symbol SGIOY and represent an interest in the Japanese-listed company.AI Generated. May Contain Errors. Read More Shionogi & Co., Ltd. Unsponsored ADR Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks39th Percentile Overall ScoreSGIOY MarketRank™: Shionogi & Co., Ltd. Unsponsored ADR scored higher than 39% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.9 / 5Analyst RatingBuy Consensus RatingShionogi & Co., Ltd. Unsponsored ADR has received a consensus rating of Buy. The company's average rating score is 3.33, and is based on 2 strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageShionogi & Co., Ltd. Unsponsored ADR has only been the subject of 1 research reports in the past 90 days.Read more about Shionogi & Co., Ltd. Unsponsored ADR's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth-3.66% Earnings GrowthEarnings for Shionogi & Co., Ltd. Unsponsored ADR are expected to decrease by -3.66% in the coming year, from $0.82 to $0.79 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Shionogi & Co., Ltd. Unsponsored ADR is 9.14, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.19.Price to Earnings Ratio vs. SectorThe P/E ratio of Shionogi & Co., Ltd. Unsponsored ADR is 9.14, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.25.Price to Earnings Growth RatioShionogi & Co., Ltd. Unsponsored ADR has a PEG Ratio of 3.28. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioShionogi & Co., Ltd. Unsponsored ADR has a P/B Ratio of 1.40. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Shionogi & Co., Ltd. Unsponsored ADR's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.00% of the float of Shionogi & Co., Ltd. Unsponsored ADR has been sold short.Short Interest Ratio / Days to CoverShionogi & Co., Ltd. Unsponsored ADR has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Shionogi & Co., Ltd. Unsponsored ADR has recently increased by 797.77%, indicating that investor sentiment is decreasing significantly. Dividend2.5 / 5Dividend StrengthModerate Dividend YieldShionogi & Co., Ltd. Unsponsored ADR pays a meaningful dividend of 1.53%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthShionogi & Co., Ltd. Unsponsored ADR does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Shionogi & Co., Ltd. Unsponsored ADR is 14.00%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Shionogi & Co., Ltd. Unsponsored ADR will have a dividend payout ratio of 17.72% next year. This indicates that Shionogi & Co., Ltd. Unsponsored ADR will be able to sustain or increase its dividend.Read more about Shionogi & Co., Ltd. Unsponsored ADR's dividend. News and Social Media2.2 / 5News Sentiment0.58 News SentimentShionogi & Co., Ltd. Unsponsored ADR has a news sentiment score of 0.58. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.89 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Shionogi & Co., Ltd. Unsponsored ADR this week, compared to 0 articles on an average week. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Shionogi & Co., Ltd. Unsponsored ADR insiders have not sold or bought any company stock.Percentage Held by Institutions1.92% of the stock of Shionogi & Co., Ltd. Unsponsored ADR is held by institutions.Read more about Shionogi & Co., Ltd. Unsponsored ADR's insider trading history. Receive SGIOY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shionogi & Co., Ltd. Unsponsored ADR and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SGIOY Stock News HeadlinesAll You Need to Know About Shionogi & Co. (SGIOY) Rating Upgrade to BuyFebruary 4, 2026 | msn.comJapan's Shionogi boosts ViiV stake to 21.7% as Pfizer exitsJanuary 20, 2026 | reuters.comBlackRock and Vanguard already own THISInstitutions own roughly 88 percent of an overlooked American oil and natural gas company. BlackRock holds 32 million shares worth about 716 million dollars, while Vanguard owns 48 million shares worth nearly 1.1 billion dollars. The company generates approximately 3.2 billion dollars in operating income against a market value of only about 8 billion dollars, and it has signed a multi-year AI agreement with Palantir to improve equipment reliability and well performance.September 14 at 1:00 AM | Monument Traders Alliance (Ad)Yomiuri: Nobel Prize Winner, Shionogi Jointly Developing New Cancer DrugNovember 15, 2025 | marketwatch.comShionogi Weighs Making Antibiotics in US Amid Rising TariffsAugust 19, 2025 | bloomberg.comSGIOY | Shionogi & Co. Ltd. ADR Annual Balance Sheet - WSJJuly 15, 2025 | wsj.comShionogi’s Naldemedine Gains Approval in China for Opioid-Induced ConstipationMay 29, 2025 | tipranks.comShionogi Amends Tender Offer for Torii Pharmaceutical SharesMay 28, 2025 | tipranks.comSee More Headlines SGIOY Stock Analysis - Frequently Asked Questions How have SGIOY shares performed this year? Shionogi & Co., Ltd. Unsponsored ADR's stock was trading at $8.98 on January 1st, 2026. Since then, SGIOY stock has increased by 1.8% and is now trading at $9.14. How were Shionogi & Co., Ltd. Unsponsored ADR's earnings last quarter? Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) announced its quarterly earnings results on Monday, August, 3rd. The company reported $0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.18. The business had revenue of $1.04 billion for the quarter, compared to the consensus estimate of $970.69 million. Shionogi & Co., Ltd. Unsponsored ADR had a trailing twelve-month return on equity of 16.13% and a net margin of 46.67%. Who are Shionogi & Co., Ltd. Unsponsored ADR's major shareholders? Top institutional investors of Shionogi & Co., Ltd. Unsponsored ADR include Birmingham Capital Management Co. Inc. AL. How do I buy shares of Shionogi & Co., Ltd. Unsponsored ADR? Shares of SGIOY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/03/2026Today9/14/2026Next Earnings (Estimated)10/26/2026Fiscal Year End3/31/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:SGIOY CIK1281721 Webshionogi.com Phone(166) 202-2161FaxN/AEmployees4,955Year Founded1878Profitability EPS (Trailing Twelve Months)$1.00 Trailing P/E Ratio9.14 Forward P/E Ratio11.15 P/E Growth3.28Net Income$1.35 billion Net Margins46.67% Pretax Margin47.81% Return on Equity16.13% Return on Assets12.09% Debt Debt-to-Equity Ratio0.01 Current Ratio1.14 Quick Ratio1.00 Sales & Book Value Annual Sales$3.32 billion Price / Sales4.69 Cash Flow$0.90 per share Price / Cash Flow10.10 Book Value$6.54 per share Price / Book1.40Miscellaneous Outstanding Shares1,701,950,000Free FloatN/AMarket Cap$15.56 billion OptionableNot Optionable Beta0.08 Social Links The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (OTCMKTS:SGIOY) was last updated on 9/14/2026 by MarketBeat.com Staff. From Our PartnersThe only 5 stocks that matterSpaceX's IPO reportedly minted 4,400 new millionaires, and OpenAI is said to be eyeing a 1 trillion dollar IPO...TradeSmith | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredWhy I went to Mount RushmoreA small miner just hit on gold in the hills surrounding Mount Rushmore, thanks to a breakthrough new technolog...Stansberry Research | SponsoredBlackRock and Vanguard already own THISInstitutions own roughly 88 percent of an overlooked American oil and natural gas company. BlackRock holds 32 ...Monument Traders Alliance | SponsoredPrint this before your next tradeBill Poulos is offering his Smart Trade Options Checklist at no cost today - normally priced at $29.97. It'...Profits Run | SponsoredMy next big call (under $1)17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of...Crypto 101 Media | SponsoredThe 2026 beginners Guide to Gold IRAsGold trades near record highs while silver just topped $81 an ounce for the first time ever. Thousands of A...Goldco Direct, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shionogi & Co., Ltd. Unsponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Shionogi & Co., Ltd. Unsponsored ADR With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SGIOY Stock Alerts